| 产品描述: | DSR-6434 是一种有效的选择性的 Toll 样受体 7 (TLR7) 激动剂,对人和小鼠 TLR7 的 EC50 分别为 7.2 nM 和 4.6 nM。DSR-6434 具有很强的抗肿瘤作用。 |
| 靶点: |
TLR7 7.2 nM (EC50, Human) TLR7 4.6 nM (EC50, Mice);TLR |
| 体外研究: |
To assess the specificity of DSR-6434 toward TLR7, an NF-κB-driven reporter assay is performed in HEK293 cells engineered to express either hTLR7, TLR8 or TLR9. In this assay, successful binding of DSR-6434 to the specific receptor leads to NF-κB activation. DSR-6434 is capable of stimulating reporter gene activity only in HEK293 cells expressing hTLR7 and not in HEK293 cells expressing the structurally similar hTLR8 or hTLR9. |
| 体内研究: |
DSR-6434 treatment (Compound 20; 0.1-1 mg/kg; intravenous injection; biweekly; for 4 weeks; B6C3F1 mice) suppresses the lung metastasis significantly, 78% inhibition at 0.1 mg/kg dosing (with no tumor metastasis at the 1 mg/kg group). |
| 参考文献: |
1. Nakamura T, et al. Synthesis and evaluation of 8-oxoadenine derivatives as potent Toll-like receptor 7 agonists with high water solubility. Bioorg Med Chem Lett. 2013 Feb 1;23(3):669-72.
2. Adlard AL, et al. A novel systemically administered Toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models. Int J Cancer. 2014 Aug 15;135(4):820-9. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.497 ml |
12.485 ml |
24.97 ml |
| 5 mM |
0.499 ml |
2.497 ml |
4.994 ml |
| 10 mM |
0.25 ml |
1.249 ml |
2.497 ml |
| 50 mM |
0.05 ml |
0.25 ml |
0.499 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |